ZUREX PHARMA, INC.

Profile

Company Names

ZUREX PHARMA, INC.

Addresses

2113 EAGLE DRIVE, MIDDLETON, WI 53562

Phone Numbers

608-203-9090

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS, BIOTECHNOLOGY

Year Incorporated:

2008

State Incorporated:

WISCONSIN

Total Amount Raised:

$30,074,988.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2023-12-14 
$3,779,232.00 
$4,000,000.00 
$220,768.00 
Equity 
5
2020-06-04 
$7,495,040.00 
$15,000,000.00 
$7,504,960.00 
Equity 
4
2018-05-25 
$2,237,490.00 
$2,999,997.00 
$762,507.00 
Equity 
3
2016-08-02 
$6,236,068.00 
$8,000,000.00 
$1,763,932.00 
Equity 
2
2014-06-23 
$4,127,158.00 
$5,118,586.00 
$991,428.00 
Equity 
1
2012-05-17 
$6,200,000.00 
$6,200,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CONNIE 
 
CURRAN 
DIRECTOR
CARMINE 
DURHAM 
EXECUTIVE OFFICER, DIRECTOR
CARMINE 
J. 
DURHAM 
EXECUTIVE OFFICER, DIRECTOR
ALEXANDER 
KASPER 
EXECUTIVE OFFICER, DIRECTOR
ALEXANDER 
M. 
KASPER 
EXECUTIVE OFFICER
GARY 
LEHMAN 
DIRECTOR
MICHAEL 
J. 
LIANG 
DIRECTOR
ANDREW 
MORGAN 
EXECUTIVE OFFICER
ROY 
A. 
MORGAN 
EXECUTIVE OFFICER
ROY 
ANDREW 
MORGAN 
EXECUTIVE OFFICER
FREDERICK 
A. 
ROBERTSON 
EXECUTIVE OFFICER, DIRECTOR
ROBERT 
 
TRUITT 
DIRECTOR
ROBERT 
TRUITT 
EXECUTIVE OFFICER, DIRECTOR
ROBERT 
B. 
TRUITT 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2023-12-14 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2020-06-04 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-05-25 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-08-02 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-06-23 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-05-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#